Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Helminth-induced alterations of the gut microbiota exacerbate bacterial colitis.

Mucosal immunology·2017
Same author

Antigen uptake in the gut: immunologic implications.

Immunology today·2014
Same author

The role of gut microbiota in programming the immune phenotype.

Journal of developmental origins of health and disease·2013
Same author

Vaginal calculi in the dolphin.

Journal of wildlife diseases·2013
Same author

Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APC(Min/+) mice.

Oncogene·2013
Same author

Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells.

Inflammatory bowel diseases·2013

Related Experiment Video

Updated: Jul 24, 2026

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing

N N Nanthakumar1, R D Fusunyan, I Sanderson

  • 1Developmental Gastroenterology Laboratory, Combined Program in Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Department of Pediatrics, Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA.

Proceedings of the National Academy of Sciences of the United States of America
|May 24, 2000
PubMed
Summary

Immature infant intestines show an excessive inflammatory response to bacteria, contributing to necrotizing enterocolitis (NEC). This exaggerated interleukin-8 (IL-8) production in fetal cells, compared to mature cells, highlights a key factor in NEC development in premature infants.

More Related Videos

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
09:11

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome
06:51

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome

Published on: July 28, 2023

Related Experiment Videos

Last Updated: Jul 24, 2026

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
09:11

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome
06:51

Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome

Published on: July 28, 2023

Area of Science:

  • Gastroenterology
  • Neonatology
  • Immunology

Background:

  • Necrotizing enterocolitis (NEC) is a severe condition affecting premature infants, linked to gut bacteria and an immature intestinal response.
  • The exact mechanisms underlying NEC pathogenesis, particularly the role of enterocyte signaling, require further elucidation.

Purpose of the Study:

  • To investigate the hypothesis that an immature enterocyte response to bacterial stimuli contributes to NEC.
  • To compare the interleukin-8 (IL-8) response to inflammatory stimuli in immature versus mature human small intestine.

Main Methods:

  • In vitro studies using Caco-2 cells (mature enterocyte model) and primary human fetal intestinal cells (H4 cells).
  • Exposure of both cell types to lipopolysaccharide (LPS) and IL-1beta, with measurement of IL-8 secretion and mRNA activity.
  • Validation using small intestinal organ cultures from fetuses and older children, subjected to LPS and IL-1beta stimulation.
  • Immunohistochemical staining to identify the cellular source of IL-8.

Main Results:

  • Immature fetal cells exhibited significantly higher IL-8 secretion (8-fold for LPS, 20-fold for IL-1beta) and IL-8 mRNA activity compared to mature Caco-2 cells.
  • Organ cultures confirmed greater IL-8 secretion (2.5-fold for LPS, 200-fold for IL-1beta) and elevated mRNA activity in fetal tissues.
  • IL-8 was primarily localized in villous and crypt epithelium, with some presence in lymphoid cells.

Conclusions:

  • Immature human enterocytes demonstrate an excessive pro-inflammatory cytokine (IL-8) response to inflammatory stimuli.
  • This heightened response in premature infants may partially explain the development of necrotizing enterocolitis upon exposure to gut bacteria.